Over-the-counter drug · UNAPPROVED DRUG OTHER
Nuvicare-Urinary Pain Relief Maximum Strength NDC 84324-042
phenazopyridine hydrochloride · Phenazopyridine hydrochloride 99.5 mg/1 · Tablet · Oral · NUVICARE LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84324-042-01 | 84324004201 | 1 BLISTER PACK in 1 CARTON (84324-042-01) / 24 TABLET in 1 BLISTER PACKMarketed from Aug 4, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nuvicare-Urinary Pain Relief Maximum Strength
- Generic name (nonproprietary)
- phenazopyridine hydrochloride
- Active ingredients
- Phenazopyridine hydrochloride — 99.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NUVICARE LLC
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 84324-042_373f0821-0e11-4eeb-968a-f592f43ae8c7SPL ID 373f0821-0e11-4eeb-968a-f592f43ae8c7SPL set ID 5fe4e4dc-f1c4-4617-b6a6-6ea16a63abfeRxCUI 1094147UNII 0EWG668W17UPC 0384324000688
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484324004201followed by a unit qualifier and the quantityPackage 84324-0042-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Excerpt only. Read the full label for complete information.